Skip to main content
Year archive

AngioLab, Inc. — 2022 filings

All 24 regulatory filings released by AngioLab, Inc. (251280) in 2022, sourced directly from the official regulator.

24 Filings
2022 Period
2022 filings (24)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2022-12-13 Korean
기업설명회(IR)개최결과
Regulatory Filings
2022-11-23 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-11-09 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2022-10-13 Korean
기타주요경영사항(자율공시)(전환우선주의 보통주 전환)
Share Issue/Capital Change
2022-10-07 Korean
[기재정정]기술도입ㆍ이전계약체결(자율공시)
Regulatory Filings
2022-08-23 Korean
임상시험단계진입ㆍ종료(자율공시)
Legal Proceedings Report
2022-08-10 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2022-08-10 Korean
기술도입ㆍ이전계약체결(자율공시)
Regulatory Filings
2022-07-06 Korean
기업설명회(IR)개최결과
Report Publication Announcement
2022-06-23 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-06-08 Korean
임상시험단계진입ㆍ종료(자율공시)
Legal Proceedings Report
2022-05-25 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2022-05-06 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2022-03-30 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-03-30 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-22 Korean
사업보고서 (2021.12)
Annual Report FY 2021
2022-03-22 Korean
임상시험단계진입ㆍ종료(자율공시)(비알코올성 지방간염(NASH) 치료제 AL101-NASH의 임상2a상 종료)
Legal Proceedings Report
2022-03-17 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2022-03-14 Korean
주주총회소집결의
AGM Information
2022-03-10 Korean
주주총회집중일개최사유신고
AGM Information
2022-03-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-02-11 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2022-01-11 Korean